Innova Captab is a finished-dose manufacturer based in India. It appears in 103 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), EFDA (ET) and ARCSA (EC). Its GMP standing is certified by FDA (GH), NAFDAC (NG) and EMA, among 4 authorities. Customs aggregates show $31.6M of exports covering 2,368 molecules to 27 destinations in 2025.
| Site | FDA FEI |
|---|---|
| BADDI, India | Not on file |
| Solan, India | Not on file |
| Solan, Nigeria | Not on file |
| Solan, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 23 | 2 |
| EFDA (ET) | 21 | None |
| ARCSA (EC) | 19 | None |
| TMDA (TZ) | 17 | None |
| CDSCO (India) | 16 | None |
| MINSA (CR) | 5 | None |
| FDA (GH) | None | 2 |
| EMA | None | 2 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $5.9M | 16 |
| 2025 | Not reported | $31.6M | 27 |
| 2024 | Not reported | $15.8M | 29 |
| 2023 | Not reported | $14.0M | 27 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Innova Captab comes back tiered against every other supplier able to file there.
Start for free